A Multicenter Randomized Double-Blind Placebo-Controlled Non-inferiority Crossover Study Evaluating the Safety and Immunogenicity of the Herpes Zoster Subunit Vaccine in Patients with Systemic Lupus Erythematosus

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Lupus Erythematosus
  • Age: Between 18 Year(s) - 90 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Female participants must use 1 effective method of avoiding pregnancy, from the time they sign consent until end of the study period unless the participant is surgically sterile (e.g., bilateral oophorectomy or complete hysterectomy), has a st

You may not be eligible for this study if the following are true:

    1. Prior administration of the Herpes Zoster (HZ) subunit vaccine (Shingrix) or the Varicella-Zoster virus vaccine live (Zostavax).
    2. Clinical HZ infection within the past 12 months.
    3. Any vaccine, including the final/booste


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.